Viridian Therapeutics's total assets for Q4 2025 were $899.42M, an increase of 55.84% from the previous quarter. VRDN total liabilities were $177.25M for the fiscal quarter, a 138.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.